Blood test study to diagnose endometriosis
Part of Women’s health & pregnancy clinical trials.
This study tests whether a new blood test can accurately detect endometriosis (tissue similar to uterine lining growing outside the uterus). You may qualify if you menstruate regularly, are between 14–49 years old, and either have confirmed endometriosis, had a negative laparoscopy (a scope procedure), or have no endometriosis symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 14 to 49 years old
- You currently menstruate regularly (have periods)
- You are not pregnant
- You do not have cancer or a history of cancer
- You are not taking GnRH agonist or antagonist medications (hormonal drugs for endometriosis or other conditions)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new blood test (HerResolve™) to see if it can accurately detect endometriosis in women who already have pelvic pain or abnormal bleeding and are scheduled for a diagnostic laparoscopy. If accurate, it could offer a less invasive way to diagnose endometriosis in the future.
This study collects blood and small tissue samples during planned gynecological surgery to better diagnose endometriosis and predict its course. It may help future patients by making diagnoses and outlook more accurate.
This study is testing if a blood test can help doctors know if a woman has endometriosis. It is for women who are having their first surgical procedure to find out if they have endometriosis.
This Phase 2 study checks whether a new lab test (using samples from your body) can detect signs specific to endometriosis. It may help improve how endometriosis is identified, especially when people are heading toward laparoscopic surgery.
This trial uses a blood-based RNA test to detect endometriosis in women who have had trouble getting pregnant for over a year. If it works, it could provide a faster and less invasive way to diagnose the condition.
This study collects menstrual blood and cheek-swab DNA to better understand endometriosis. It may help researchers find markers that could eventually lead to earlier diagnosis and improved treatment planning.
Hear when a new Endometriosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.